We help you empower your users to take the right dose at the right time

Increased adherence has proven large cost savings for clinical trials, by reducing the amount of patients needed to reach reliable results.

Table showing average savings in clinical trails with 1% increased adherence. 

...at 39%

Average cost savings per 1% improvement in IMP adherence

Estimated wasted capital on cost of enrolling additional patients at 40% non-adherence

...at 39%

Estimated additional patients needed to maintain statistical power at 40% non-adherence

Trial phase

$ 19,036

$ 50,904

$ 335,725

$ 167,050

$ 655,475

$ 2,171,250 

$ 11,960,000

$ 6,093,750

41

110

447

228

42

113

460

234

Phase I 

 

Phase II  

Phase III

Phase IV

$ 636,439

$ 2,120,346

$ 11,624,275

$ 5,926,700

Our adherence solutions support patients in managing their medical treatment and provides real-time data of their adherence. The solutions can be adapted to your needs and IT-system. 

Want to find out more? 

...or let us send an email to you. *no spam guarantee